Effects of Tibetan Yoga on Fatigue and Sleep in Cancer

藏式瑜伽对癌症疲劳和睡眠的影响

基本信息

  • 批准号:
    8020103
  • 负责人:
  • 金额:
    $ 30.26万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2006
  • 资助国家:
    美国
  • 起止时间:
    2006-03-10 至 2013-01-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Cancer and its treatment are associated with considerable distress, impaired quality of life, poor mental health, and reduced physical function. This is particularly true for women with breast cancer who receive multimodal treatment over an extended period of time. Many women undergo surgery and chemotherapy, which are often followed by radiotherapy. It is important to develop programs that can be incorporated into the treatment schedule that can help ameliorate the treatment-related morbidity that accumulates over time. Research suggests that stress-reduction programs tailored to the cancer treatment setting may help patients cope with the acute effects of treatment and improve their quality of life after treatment. Yoga, an ancient Eastern science, incorporates stress-reduction techniques including regulated breathing, visual imagery, and meditation, as well as various postures. Although different forms of yoga are practiced in many Eastern countries, most of what is known about yoga in the West comes from the Indian tradition. Less well know are the yogic practices from Tibet. For thousands of years, Tibetan's have been employing a form of yoga that incorporates controlled breathing and visualization, mindfulness techniques, and postures. We have designed and pilot-tested a Tibetan yoga program for cancer patients and found that it is feasible to conduct the intervention, and there is some initial indication that the intervention improves adjustment. We hypothesize that the yoga program we designed will be particularly useful for women with breast cancer who are undergoing adjuvant treatment for their disease as the focus is on controlled breathing, visualization, and mindfulness techniques, as well as some low impact gentle postures. The proposed study will assess the physical and psychological benefits of a Tibetan yoga program for women with breast cancer undergoing adjuvant chemotherapy. Patients with breast cancer who are scheduled to receive chemotherapy will be randomly assigned to either a Tibetan yoga group or an Educational Support group. This research will also evaluate the extent to which psychosocial factors mediate and/or moderate the intervention program and predict patients' recovery and adjustment to treatment. The effects of the intervention should be evident throughout recovery and across physical and psychological indices.
描述(由申请人提供):癌症及其治疗与相当大的痛苦、生活质量受损、心理健康状况不佳和身体机能下降有关。对于长期接受多模式治疗的乳腺癌女性来说尤其如此。许多女性接受手术和化疗,随后通常进行放疗。制定可纳入治疗计划的计划非常重要,这有助于改善随时间累积的治疗相关发病率。研究表明,针对癌症治疗环境量身定制的减压计划可以帮助患者应对治疗的急性影响并改善治疗后的生活质量。瑜伽是一门古老的东方科学,融合了减压技巧,包括调节呼吸、视觉想象、冥想以及各种姿势。尽管许多东方国家都练习不同形式的瑜伽,但西方对瑜伽的了解大多来自印度传统。西藏的瑜伽练习却鲜为人知。几千年来,藏族一直采用一种瑜伽形式,结合了控制呼吸和想象、正念技巧和姿势。我们为癌症患者设计并试点了藏式瑜伽项目,发现进行干预是可行的,并且有一些初步迹象表明干预可以改善调整。我们假设我们设计的瑜伽课程对于正在接受辅助治疗的乳腺癌女性特别有用,因为重点是控制呼吸、想象和正念技巧,以及一些低冲击力的温和姿势。拟议的研究将评估西藏瑜伽项目对接受辅助化疗的乳腺癌女性的身体和心理益处。计划接受化疗的乳腺癌患者将被随机分配到西藏瑜伽组或教育支持组。这项研究还将评估心理社会因素介导和/或调节干预计划的程度,并预测患者的康复和对治疗的调整。干预措施的效果在整个康复过程中以及身体和心理指标上应该是显而易见的。

项目成果

期刊论文数量(2)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Lorenzo Cohen其他文献

Lorenzo Cohen的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Lorenzo Cohen', 18)}}的其他基金

Opioid-Sparing Effects of Nurse-Delivered Hypnosis During Breast Cancer Surgery
乳腺癌手术期间护士催眠的阿片类药物节省效果
  • 批准号:
    10668632
  • 财政年份:
    2023
  • 资助金额:
    $ 30.26万
  • 项目类别:
Personalized Integrative Oncology: Targeted Approaches for Optimal Outcomes
个性化综合肿瘤学:实现最佳结果的针对性方法
  • 批准号:
    8838465
  • 财政年份:
    2014
  • 资助金额:
    $ 30.26万
  • 项目类别:
Community-Based, Phase III Trial of acupuncture to treat chronic Xerostomia
针灸治疗慢性口干症的社区 III 期试验
  • 批准号:
    8458083
  • 财政年份:
    2012
  • 资助金额:
    $ 30.26万
  • 项目类别:
Community-Based, Phase III Trial of acupuncture to treat chronic Xerostomia
针灸治疗慢性口干症的社区 III 期试验
  • 批准号:
    8643775
  • 财政年份:
    2012
  • 资助金额:
    $ 30.26万
  • 项目类别:
Community-Based, Phase III Trial of acupuncture to treat chronic Xerostomia
针灸治疗慢性口干症的社区 III 期试验
  • 批准号:
    8296964
  • 财政年份:
    2012
  • 资助金额:
    $ 30.26万
  • 项目类别:
Placebo Controlled Trial Of Acupuncture To Prevent Radiation-Induced Xerostomia
针灸预防辐射引起的口干症的安慰剂对照试验
  • 批准号:
    8230482
  • 财政年份:
    2011
  • 资助金额:
    $ 30.26万
  • 项目类别:
Placebo Controlled Trial Of Acupuncture To Prevent Radiation-Induced Xerostomia
针灸预防辐射引起的口干症的安慰剂对照试验
  • 批准号:
    8444600
  • 财政年份:
    2011
  • 资助金额:
    $ 30.26万
  • 项目类别:
Placebo Controlled Trial Of Acupuncture To Prevent Radiation-Induced Xerostomia
针灸预防辐射引起的口干症的安慰剂对照试验
  • 批准号:
    8607153
  • 财政年份:
    2011
  • 资助金额:
    $ 30.26万
  • 项目类别:
Placebo Controlled Trial Of Acupuncture To Prevent Radiation-Induced Xerostomia
针灸预防辐射引起的口干症的安慰剂对照试验
  • 批准号:
    8043902
  • 财政年份:
    2011
  • 资助金额:
    $ 30.26万
  • 项目类别:
Yoga for women with breast cancer undergoing radiotherapy
适合接受放射治疗的乳腺癌女性的瑜伽
  • 批准号:
    8041091
  • 财政年份:
    2010
  • 资助金额:
    $ 30.26万
  • 项目类别:

相似海外基金

3D Engineered Model of Microscopic Colorectal Cancer Liver Metastasis for Adjuvant Chemotherapy Screens
用于辅助化疗筛选的显微结直肠癌肝转移 3D 工程模型
  • 批准号:
    10556192
  • 财政年份:
    2023
  • 资助金额:
    $ 30.26万
  • 项目类别:
Developing Digital Pathology Biomarkers for Response to Neoadjuvant and Adjuvant Chemotherapy in Breast Cancer
开发数字病理学生物标志物以应对乳腺癌新辅助和辅助化疗
  • 批准号:
    10315227
  • 财政年份:
    2021
  • 资助金额:
    $ 30.26万
  • 项目类别:
Circulating Tumour DNA Analysis Informing Adjuvant Chemotherapy in Stage III Colorectal Cancer: A Multicentre Phase II/III Randomised Controlled Trial (DYNAMIC-III)
循环肿瘤 DNA 分析为 III 期结直肠癌辅助化疗提供信息:多中心 II/III 期随机对照试验 (DYNAMIC-III)
  • 批准号:
    443988
  • 财政年份:
    2021
  • 资助金额:
    $ 30.26万
  • 项目类别:
    Operating Grants
Establishment of new selection system for adjuvant chemotherapy of colorectal cancer
结直肠癌辅助化疗新选择体系的建立
  • 批准号:
    20K09011
  • 财政年份:
    2020
  • 资助金额:
    $ 30.26万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Improved survival by Helicobacter pylori-modulated immunity in gastric cancer patients with adjuvant chemotherapy
幽门螺杆菌调节免疫力可改善接受辅助化疗的胃癌患者的生存率
  • 批准号:
    19K09130
  • 财政年份:
    2019
  • 资助金额:
    $ 30.26万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
A new strategy of adjuvant chemotherapy for lung cancer based on the expression of anti-aging gene Klotho
基于抗衰老基因Klotho表达的肺癌辅助化疗新策略
  • 批准号:
    19K18225
  • 财政年份:
    2019
  • 资助金额:
    $ 30.26万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Novel candidate factors predicting the effect of S-1 adjuvant chemotherapy of pancreatic cancer
预测胰腺癌S-1辅助化疗效果的新候选因素
  • 批准号:
    18K16337
  • 财政年份:
    2018
  • 资助金额:
    $ 30.26万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Project 2-Metabolic Modulation of Myeloid-Derived Suppressor Cells to Increase Efficacy of Neo adjuvant Chemotherapy and Immunotherapy
项目2-骨髓源性抑制细胞的代谢调节以提高新辅助化疗和免疫疗法的疗效
  • 批准号:
    10005254
  • 财政年份:
    2018
  • 资助金额:
    $ 30.26万
  • 项目类别:
Radiogenomic tools for prediction of breast cancer neo-adjuvant chemotherapy response from pre-treatment MRI
通过治疗前 MRI 预测乳腺癌新辅助化疗反应的放射基因组学工具
  • 批准号:
    9763320
  • 财政年份:
    2018
  • 资助金额:
    $ 30.26万
  • 项目类别:
Analysis of the molecular mechanism for the prognostic biomarker of adjuvant chemotherapy
辅助化疗预后生物标志物的分子机制分析
  • 批准号:
    18K07341
  • 财政年份:
    2018
  • 资助金额:
    $ 30.26万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了